These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19193507)

  • 1. Discordance between results of biomarkers of fibrosis shows that it is at least a "ménage à deux".
    Munteanu M; Lebray P; Massard J; Moussalli J; Varaut A; Ngo Y; Thabut D; Imbert-Bismut F; Benhamou Y; Ratziu V; Poynard T
    Gastroenterol Clin Biol; 2009 Feb; 33(2):133-4. PubMed ID: 19193507
    [No Abstract]   [Full Text] [Related]  

  • 2. Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C.
    Fontanges T; Bailly F; Trepo E; Chevallier M; Maynard-Muet M; Nalet B; Beorchia S; Pillon D; Moindrot H; Froissart B; Slaoui M; Tinel X; Pradat P; Trepo C
    Gastroenterol Clin Biol; 2008 Oct; 32(10):858-65. PubMed ID: 18775614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes?
    Peters L; Rockstroh JK
    Curr Opin HIV AIDS; 2010 Nov; 5(6):517-23. PubMed ID: 20978395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J; Łoch T; Jabłońska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
    Cross TJ; Rizzi P; Berry PA; Bruce M; Portmann B; Harrison PM
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):730-8. PubMed ID: 19430302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
    Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
    Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
    Testa E; Malfatti F; Milazzo S; Cordiviola C; Cotellessa T; Marabotto E; Giannini E; Ceppa P; Mamone M; Risso D; Testa R
    Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis.
    Iacobellis A; Mangia A; Leandro G; Clemente R; Festa V; Attino V; Ricciardi R; Giacobbe A; Facciorusso D; Andriulli A
    Am J Gastroenterol; 2005 Apr; 100(4):868-73. PubMed ID: 15784034
    [No Abstract]   [Full Text] [Related]  

  • 13. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C.
    Gordon A; Bailey MJ; Gibson PR; Roberts SK
    J Gastroenterol Hepatol; 2005 Jun; 20(6):825-32. PubMed ID: 15946128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.
    Maor Y; Calès P; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
    Haemophilia; 2007 Nov; 13(6):722-9. PubMed ID: 17973848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
    Carrión JA; Fernández-Varo G; Bruguera M; García-Pagán JC; García-Valdecasas JC; Pérez-Del-Pulgar S; Forns X; Jiménez W; Navasa M
    Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of FibroIndex.
    Halfon P; Penaranda G; Renou C; Bourliere M
    Hepatology; 2007 Jul; 46(1):280-1; author reply 281-2. PubMed ID: 17596884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.